| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |